Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 19 | 16 | −3 |
| Shares | 834.5K | 673.6K | −160.9K (−19.3%) |
| Value | $1.30M | $558.0K | −$744.0K (−57.1%) |
New holders (3)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 90,517 | $75.0K | 0.00% |
| Virtu Financial LLC | 53,594 | $44.0K | 0.00% |
| Veritable, L.P. | 16,868 | $14.0K | 0.00% |
Sold out (6)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Marshall Wace, LLP | 131,196 | $205.0K |
| Two Sigma Investments, LP | 104,120 | $162.0K |
| Two Sigma Advisers, LP | 73,800 | $115.0K |
| UBS Group AG | 4,820 | $8.00K |
| Tower Research Capital LLC (TRC) | 3,924 | $6.00K |
| Royal Bank of Canada | 57 | $0 |